Jörg Klumbis

Jörg Klumbis has a diverse work experience spanning over several companies. Jörg is currently serving as the CFO of Peptomyc, a company focused on developing cell penetrating peptides for cancer treatment. Prior to this, Jörg worked as a Co-founder and Partner at AIO Health Pro S.L., where they acted temporarily as CFO and provided services to the health sector. Jörg also worked as a Partner at WANRAX Consultant SL.

Jörg has extensive experience in the pharmaceutical industry, having served as the Executive Director of Finance and Administration at Invent Farma, a company that develops, manufactures, and markets generic drugs. Additionally, they worked as CFO at Laboratorios LETI, a multinational pharmaceutical group with expertise in immunotherapy vaccination and dermatology. Jörg also held various roles at Merck Group, including Head of Controlling and Project Controller.

Prior to their involvement in the pharmaceutical industry, Jörg worked at Uhde Edeleanu, where they served as Assistant Head of Project Controlling Department, Senior Project Controller, Business Controller, and Assistant to Management.

Overall, Jörg Klumbis has a strong background in finance and administration, with a specialization in the pharmaceutical industry.

Jörg Klumbis completed their high school education at Leibniz Gymnasium in Remscheid, where they earned their high school diploma. Following this, they attended Technische Universität Darmstadt from 1984 to 1991, where they specialized in electrical engineering and obtained a degree in Industrial Engineering. Later, in 1998 and 1999, Jörg attended IESE Business School to pursue a PDD (Program for Management Development) degree, although their field of study during this period is not specified.